A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Príomhchruthaitheoir: | Islam, Nahidul |
---|---|
Rannpháirtithe: | Talukder, Mesbah |
Formáid: | Tráchtas |
Teanga: | English |
Foilsithe / Cruthaithe: |
Brac University
2023
|
Ábhair: | |
Rochtain ar líne: | http://hdl.handle.net/10361/22025 |
Míreanna comhchosúla
-
TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
de réir: Afroza, Halima
Foilsithe / Cruthaithe: (2024) -
Biologics and Biosimilars as Treatment Options for Psoriasis
de réir: Moya, Amena Khatun
Foilsithe / Cruthaithe: (2023) -
Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
de réir: Bishakha, Adwiza Chakraborty
Foilsithe / Cruthaithe: (2024) -
Safety and efficacy of dutasteride for male Androgenetic Alopecia
de réir: Islam, S.M. Zahidul
Foilsithe / Cruthaithe: (2024) -
Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
de réir: Khandker, Tahia Anjum
Foilsithe / Cruthaithe: (2024)